Indirect treatment comparisons of glucoselowering agents have previously been reported in the literature in the absence of headtohead trials
K., Pakarinen, M., & STEP 2 Study Group
(2019) "Glucagon-like peptide 1 (GLP-1)." Food and Drug Administration (FDA) "Ozempic (semaglutide) injection Prescribing Information." Wang, K., Feng, X., Chai, L., et al
Many patients experience hunger return or weight regain several years after sleeve gastrectomy or gastric bypass
Key risk factors include: Rapid weight loss: Losing weight quickly significantly increases gallstone risk Female sex: Women are two to three times more likely to develop gallstones than men Age over 40 years: Gallstone prevalence increases with age Obesity: Higher baseline BMI correlates with increased risk Previous history of gallstones: Prior biliary disease predicts recurrence Family history: Genetic factors contribute to gallstone susceptibility Certain ethnicities: Native American and Hispanic populations have higher baseline rates Estrogen exposure: Oral contraceptives, hormone replacement therapy, and multiple pregnancies Diabetes and dyslipidemia: Metabolic conditions affecting bile composition Prolonged fasting or TPN use: Reduces gallbladder contraction Patients should be educated about warning signs that may indicate gallstone complications
